A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

  1. Coveler, A.L.
  2. Reilley, M.J.
  3. Zalupski, M.
  4. Macarulla, T.
  5. Fountzilas, C.
  6. Ponz-Sarvisé, M.
  7. Nagrial, A.
  8. Uboha, N.V.
  9. Frentzas, S.
  10. Overman, M.
  11. Noonan, A.
  12. Messersmith, W.A.
  13. Pavlakis, N.
  14. Mettu, N.B.
  15. Bisha, I.
  16. Wang, Y.
  17. Smith, P.
  18. Murtomaki, E.
  19. Bielska, A.A.
  20. Bragulat, V.
  21. Cooper, Z.A.
  22. Kumar, R.
  23. Spigel, D.R.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Argitalpen urtea: 2024

Alea: 30

Zenbakia: 20

Orrialdeak: 4609-4617

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-24-0499 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus